DENTSPLY Sirona (XRAY) News
What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Management reduced full-year 2026 sales guidance to approximately $3.5 billion. Wellspect Healthcare revenue grew 10% year over year to $92 million.…

XRAY, BROS and GECC have been added to the Zacks Rank #5 (Strong Sell) List on November 13, 2026.…

DENTSPLY SIRONA Inc. ( XRAY ) Q3 2026 Earnings Call November 5, 2026 4:30 PM EST Company Participants Suzanne Hatcher Daniel Scavilla - President, CEO, Interim Principal Financial Officer & Director John Fortson - Execut…

DENTSPLY SIRONA NASDAQ: XRAY lowered its full-year earnings outlook after third-quarter sales fell across its dental businesses, as pressure from European distributor inventory reductions, the Middle East conflict and hi…

DENTSPLY SIRONA's Q3 sales decline 7.6% amid dental weakness, while Wellspect growth provides support. The company lowers its 2026 outlook.…

While the top- and bottom-line numbers for Dentsply (XRAY) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street e…

Dentsply International (XRAY) came out with quarterly earnings of $0.29 per share, missing the Zacks Consensus Estimate of $0.3 per share. This compares to earnings of $0.37 per share a year ago.…

News Summary Q3 2026 net sales of $836 million Q3 2026 GAAP gross margin of 52.9% , GAAP diluted loss per share of ($0.01) Q3 2026 adjusted gross margin of 54.5% , adjusted EBITDA margin of 17.3% , adjusted EPS of $0.29 …

DENTSPLY SIRONA faces Q3 earnings pressure from weak dental demand, tariff costs and segment challenges, while Wellspect's growth may offer some relief.…

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket p…

CHARLOTTE, N.C., Oct. 20, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will host an investor conference call and live webcast on Thurs…

XRAY expands its U.S. distribution reach through Midwest Dental, aiming to boost digital dentistry adoption and broaden access to its technology portfolio.…

What happened Dentsply Sirona Inc. (NASDAQ: XRAY) said on October 8, 2026, that lenders consented to amendments to its revolving credit facility and related note agreements. The company entered the Third Amendment to Cre…

The expanded relationship builds on a series of agreements announced this year, strengthening Dentsply Sirona's North American dealer network and giving more customers access to its products and technology. The expanded …

Shares of DENTSPLY SIRONA Inc. (NASDAQ: XRAY - Get Free Report) hit a new 52-week low on Friday. The company traded as low as $9.36 and last traded at $9.38, with a volume of 9306449 shares. The stock had previously clos…

Engineers Gate Manager LP boosted its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ: XRAY) by 451.5% in a recent quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commi…

XRAY's digital dentistry, R&D and restructuring support growth, but CAD/CAM, implants, SureSmile and tariff pressures pose near-term risks.…

XRAY beat Q2 earnings and revenue estimates, held 2026 guidance and improved cash flow, but falling sales and margin pressure cloud the recovery.…

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket p…

CHARLOTTE, N.C., Sept. 03, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the Baird 2026 Global Healthcare Conferenc…

"I'll give you 950 billion reasons to buy bonds right now," says Thomas Hayes, who gives a contrarian take on why investors should bolster their portfolios in fixed income. He discusses the "seasonality effect," a crowde…
Kept in their own lane. A press release is the company talking, not reporting.
No upcoming events in the feeds.
Quiet tape today.

